Farmavita.Net - Pharmaceutical Licensing Network

Home

Licensing opportunity

Demand: In-vitro Models of Ginival Tissue

The "TOP 10 Global Pharma Company" is seeking:

Novel in vitro models that mimic oral gingival tissue

They are looking for potential partners with unique innovative technologies to meet changing needs of global consumers. Seeker is the leading research-based pharmaceutical and healthcare company in the world, employing 100,000+ people in 100+ countries.

Innovative Medicines Offer

NO-donating molecule

Early stage patented NO-donating molecule

Licensing out of a novel and patented NO-donating molecule with strong inhibitory activity specifically against melanoma and breast cancer cell growth.

Generic Medicine Demand

Licenses-in needs for generic drugs

JSC Valentis Pharma is looking for EU CTD Dossiers with bulk supply of Amoxicillinum (+ ac clavulanicum); Azithromycine; Cefuroxime; Cetirizine; Cinnarizine; Ciprofloxacin; Clarithromycin; Clemastine; Clindamycine; Clotrimazole; Diclofenac; Doxazosin; Doxycycline; Drotaverine; Ketoprofen; Ketorolac; Loratadine; Nimesulide; Omeprazole; Pentoxifylline; Terbinafine; Tramadol; Vinpocetine.

License territory would be Lithuania, Latvia, Poland.

Generic Medicines - Offer

EU-CTD Dossiers of Generic Drugs with Product Supply

Farmavita.Net member from Portugal has several EU-CTD dossier of Generic Drugs to offer for international market: Aciclovir Oral suspension (80 mg/ml), Deflazacort (6 and 30 mg, tablets), Omeprazole (10, 20 and 40 mg, capsules) and Piroxicam (20 mg, dispersible tablets).

OTC / Nutraceutical Demand

Drotaverin

License-in needs for DROTAVERIN

Client of Farmavita.Net is looking for EU CTD Dossier with bulk supply of Drotaverine.

Sales foreast for first year is 100.000 packs.

License territory would be Poland. Licensee is established company with well developed sales and distribution capability.

Please, contact us for more details.

API/Technology Demand

High-speed immune detection apparatus

Substance with high affinity for large antigen molecules

A company seeks a process of making high-affinity antibodies (or other substances) that can bind rapidly to antigens of large molecular sizes, such as proteins. Their aim is to develop a high-speed immune detection apparatus.

Market Report

Croatia - Pharmaceuticals and Biotechnology

PHARMACEUTICALS AND BIOTECHNOLOGY IN CROATIA
Attractive Investment Opportunities

The pharmaceutical industry has a long tradition in Croatia and ‘know-how', promising successful future development of this and related industries. The most important pharmaceutical companies in Croatia are Pliva, Belupo, and Jadran Galenski Laboratorij. The pharmaceutical industry represents 4% of the total manufacturing industry employing 1.7% of the total employment in manufacturing in Croatia.

Complete report (80 pages) is available for FREE downloat at Farmavta.Net Downloads Section.

Life Science Article

Gastroretentive floating tablets of Famotidine

FORMULATION AND EVALUATION OF GASTRORETENTIVE FLOATING TABLETS OF FAMOTIDINE

Gastroretentive drug delivery systems are the systems which are retained in the stomach for a longer period of time and thereby improve the bioavailability of drugs. Different approaches for gastroretentive dosage forms include floating, raft, expanding or swelling, bioadhesive or mucoadhesive and high/low-density systems. Famotidine, an anti-ulcer drug, suffers from poor bioavailability (50%), as Famotidine is very less soluble in alkaline pH. Famotidine used in combination with antacids promotes local delivery of these drugs to the receptor of the parietal cell wall. Local delivery also increases bioavailability at the stomach wall receptor site and increases the efficacy of drugs to reduce acid secretion. Thus, the present work is aimed to formulate floating tablets of famotidine using an effervescent approach for gastroretentive drug delivery system.

Events

European Forecasting Excellence Summit

3rd Annual European Forecasting Excellence Summit

20-22 April 2009, Madrid, Spain

With the changing healthcare environment, it has never been more essential for organisations to have accurate and first-rate forecasts, to enable strategic business decision-making and stay ahead of the competition. This two day intensive Summit will address the most important aspects of Forecasting and Marketing in Europe. Following on from years of highly successful Global Pharmaceutical Sales conferences eyeforpharma's latest offering in this field guarantees to take forecasting excellence to the next level.

Regulatory Affairs News

eCTD

Embrace the eCTD and stay ahead

As one door closes, businesses must look for their next opening. Today, the traditional strongholds of the pharmaceutical industry, the US and Europe, are witnessing a downturn in growth to around 6% a year. This is the result not only of problems in the broader economy, but also the loss of marketing exclusivity by products in a number of major therapeutic categories; lower contributions from new products because of increased scrutiny of their value; and slower take-up by doctors and healthcare systems.